Belpointe Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $940K | Buy |
13,617
+3,028
| +29% | +$209K | 0.04% | 376 |
|
|
2025
Q1 | $735K | Buy |
10,589
+5,193
| +96% | +$361K | 0.04% | 425 |
|
|
2024
Q4 | $751K | Sell |
5,396
-5,938
| -52% | -$826K | 0.05% | 399 |
|
|
2024
Q3 | $1.35M | Buy |
11,334
+8,249
| +267% | +$982K | 0.08% | 244 |
|
|
2024
Q2 | $440K | Buy |
3,085
+119
| +4% | +$17K | 0.03% | 485 |
|
|
2024
Q1 | $381K | Buy |
2,966
+702
| +31% | +$90.1K | 0.03% | 513 |
|
|
2023
Q4 | $234K | Buy |
2,264
+32
| +1% | +$3.31K | 0.02% | 616 |
|
|
2023
Q3 | $203K | Sell |
2,232
-1,234
| -36% | -$112K | 0.02% | 600 |
|
|
2023
Q2 | $280K | Sell |
3,466
-4,116
| -54% | -$333K | 0.03% | 477 |
|
|
2023
Q1 | $603K | Buy |
7,582
+1,270
| +20% | +$101K | 0.03% | 485 |
|
|
2022
Q4 | $427K | Sell |
6,312
-58
| -0.9% | -$3.93K | 0.03% | 608 |
|
|
2022
Q3 | $318K | Buy |
6,370
+3,212
| +102% | +$160K | 0.02% | 667 |
|
|
2022
Q2 | $176K | Buy |
3,158
+840
| +36% | +$46.8K | 0.01% | 877 |
|
|
2022
Q1 | $129K | Buy |
+2,318
| New | +$129K | 0.01% | 1100 |
|
|
2021
Q3 | – | Sell |
-2,640
| Closed | -$111K | – | 1230 |
|
|
2021
Q2 | $111K | Buy |
+2,640
| New | +$111K | 0.01% | 1085 |
|